VisCardia Press Releases - EIN Presswire - Press Release Distribution Service

Published on December 2, 2025 - 09:00 GMT

VisCardia Secures $40 Million Growth Financing to Advance VisONE™ Heart Failure Therapy Toward PMA Approval

PORTLAND, OR, UNITED STATES, December 2, 2025 /⁨EINPresswire.com⁩/ -- VisCardia, Inc., a medical device company pioneering a novel cardiac-support therapy for patients with heart failure, today announced it has secured $40 million in growth financing to …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 10, 2025 - 14:52 GMT

VisCardia Wins Inaugural MedTech Innovator Impact Award at 32nd Annual Medical Device & Digital Health Conference

PORTLAND, OR, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- VisCardia, Inc., an alumni company of MedTech Innovator, has been awarded the first-ever 2025 MedTech Innovator Impact Award on Friday, June 6, during the live pitch session at the 32nd …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on May 21, 2025 - 15:49 GMT

VisCardia Honored with Prestigious Innovation Award at EuroPCR 2025 for Groundbreaking Heart Failure Therapy

PARIS, FRANCE, May 21, 2025 /⁨EINPresswire.com⁩/ -- VisCardia, Inc., the developer of a disruptive therapy for heart failure, proudly announced today that it has received the prestigious Jon DeHaan Foundation Award for Innovation in Cardiology at EuroPCR …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on April 4, 2025 - 10:00 GMT

ACC.25 Panel of Experts Awards VisCardia Top Honors for Innovation in MedTech

VisCardia wins ACC.25 Innovation Pitch Competition Award PORTLAND, OR, UNITED STATES, April 4, 2025 /⁨EINPresswire.com⁩/ -- VisCardia, Inc. is honored to announce that our team has won the judge’s vote during the Future Hub ACC.25 Innovation Pitch …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on November 5, 2024 - 11:00 GMT

CMS Agrees With VisCardia on the Value of Synchronized Diaphragmatic Stimulation

PORTLAND, OR, UNITED STATES, November 5, 2024 /⁨EINPresswire.com⁩/ -- VisCardia, Inc. announced today that they have received payment assignments for the designated CPT III codes for VisONE SDS® therapy by the Centers for Medicare and Medicaid Services ( …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 30, 2024 - 09:00 GMT

VisCardia Receives US FDA IDE Approval to Start the RECOVER HF Clinical Study

PORTLAND, OREGON, UNITED STATES, July 30, 2024 /⁨EINPresswire.com⁩/ -- VisCardia, Inc. announced today the U.S. Food and Drug Administration (FDA) approval of an Investigational Device Exemption (IDE) to study the safety and effectiveness of the VisONE SDS …

Distribution channels: Banking, Finance & Investment Industry, Companies ...